Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Cipher Pharmaceuticals Inc. T.CPH

Sector: Healthcare | Sub-Sector: Drug Manufacturers - Specialty & Generic
Alternate Symbol(s):  CPHMF | CPHR

Cipher Pharmaceuticals Inc is a specialty pharmaceutical company that develops improved formulations of existing drugs. It search for products based on currently marketed molecules paired with a novel drug delivery technology for enhanced performance.
Price: $13.65 | Change: $-0.22 | %Change: -1.59%
Volume: 67,161 | Day High/Low: 14.00/13.60 | 52 Week High/Low: 19.52/7.41
View modes: 
0 stars

RE:RE:RE:Biosyent V.Rx is dropping maybe Cipher will buy it?

Ys you are right Tunee, Biosyent's stock price was way ahead of its actual value because it was based upon everything going perfectly for the next 2 years, which as you say has proven to be much to...read more
0 stars

RE:RE:Biosyent V.Rx is dropping maybe Cipher will buy it?

The reason Rx is tanking is there main product has competition entering the market.  Even at todays prices Rx is trading at a 70% premium to its peers.  Its hard to judge the future because i don't...read more
0 stars

RE:Biosyent V.Rx is dropping maybe Cipher will buy it?

If Cipher can buy 50.1 % of Bioysent they could then do a stock swap for the rest. So if Cipher shares are worth say $16.00 when they buy the 50.1% and Bioysent shares are worth $8.00 per share then...read more
3 stars

Biosyent V.Rx is dropping maybe Cipher will buy it?

Biosyent is getting down to a valuation where Cipher can buy up Biosyent for a good price. It has some derm products. It may be a good buy at these prices for Cipher. Comments?    Biosyent needs $ to...read more
3 stars

Absorica USA 2015 sales & CPH stock price expectations

My opinion of Absorica USA sales Q1 2015 results when they come out. Above 20% USA market share okay, Stock price goes up to maybe $16.00.  Above 20.5% USA market share good. Stock...read more
5 stars

RE:RE:RE:RE:RE:RE:RE:ffs

I recall Ceo describing the sort of sales force he thought was required in one of the cc or presentations - a ratio of reps to doctors I think.  Now they are doing it.  Seems to me that they are...read more
3 stars

RE:RE:RE:RE:RE:RE:ffs

I don't think it's dead, either.  But they didn't buy its rights for RA.  Their sales channel is geared towards dermatologists.  A big plus re. Innocutis is that they're buying infrastructure, as well...read more
0 stars

RE:RE:RE:RE:RE:ffs

I'm not entirely convinced CF101 is dead. Just because it didnt show benefit for Psoriasis doesnt mean its dead for Rhumatoid Arthritis. I believe that in my readings I read that RA is also a bigger...read more
3 stars

RE:RE:RE:RE:ffs

I hear you longhaul, the Isreali thing felt more like a hail mary pass, it could have but didn't. Now like you I just can't find realtime numbers on this. Maybe because everything is a couple years...read more
0 stars

RE:RE:RE:ffs

There is no risk of any generic Absorica being available sooner then 2017 or more likely 2018 as that is how long the court battle will take at the minimum, unless Cipher and partners intend to give...read more
3 stars

RE:RE:RE:ffs

Glad to help, and you're right--very counter-intuitive.  You still see people on your ignore list if you're not logged in or on your phone or something, but it just makes the screaming funny rather...read more
2.5 stars

RE:RE:ffs

Holy smokes, I owe you a big thanks longhaul62, I was trying to ignore via the other users' profile options, what you suggested works like a charm. Seems counter-intuitive since I assumed the mail...read more
3 stars

Numbers

I haven't been able to find any revenue numbers for Sitavig.  It's approved in the EU, and has been commercial in the US for ~ one year.  Total net revenue for Innocutis 2014 calendar year was 10.1MM....read more
0 stars

Styless you lied & you lost, I won simple

Hey stupidess CPH never went up to $20 & did not go down to $10 in the past 4 months, so how could my investments have done that? Gotcha!!  You are cracking up lying about everything...read more
0 stars

RE:RE:RE:RE:RE:RE:RE:RE:RE:so

Great post biggerr. Post more like this and with links if you can. Good or bad as long as it is factual it is very good to see on this board. Better then the desparate bashers who constantly lie on...read more
5 stars

RE:RE:RE:RE:RE:RE:RE:RE:so

don't forget the 3 creams which CPH bought from Astion in February, we don't know how they will sell  rate and reply
4 stars

RE:ffs

Hi ffs If you click on the email button it should take you to a screen where you can ignore someone.  I personally hate doing that, but had to get rid of that screamer. Good luck......(and do you...read more
3 stars

RE:RE:RE:RE:RE:RE:RE:RE:so

right. Keep dreaming. ha  rate and reply
3.5 stars

ffs

If the primary purpose of your post is to talk about other posters on this board, you are wasting everyone's time including your own. Exchange emails and argue about who made how much and when to...read more
0 stars

RE:RE:RE:RE:RE:RE:RE:so

You are so busted, you don't own those others unless own only a few hundred dollars worth of each, so you really aren't making significant money like I am. If I was up like you say you are in massive...read more